Sg Americas Securities, LLC Esperion Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 77,049 shares of ESPR stock, worth $185,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,049

Previous 37,414 105.94%

Holding current value

$185,688

Previous $83,000 53.01%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$1.61 - $2.73 $63,812 - $108,203	39,635 Added 105.94%	77,049 $127,000
Q2 2024 Jul 12, 2024	BUY	$1.84 - $3.24 $21,450 - $37,771	11,658 Added 45.26%	37,414 $83,000
Q1 2024 May 06, 2024	BUY	$2.02 - $3.02 $52,027 - $77,783	25,756 New	25,756 $69,000
Q1 2023 Apr 28, 2023	SELL	$1.46 - $7.3 $1,423 - $7,117	-975 Reduced 6.11%	14,994 $24,000
Q4 2022 Feb 02, 2023	SELL	$5.09 - $8.5 $340,622 - $568,820	-66,920 Reduced 80.73%	15,969 $99,000
Q3 2022 Oct 31, 2022	BUY	$5.45 - $8.13 $116,117 - $173,217	21,306 Added 34.6%	82,889 $555,000
Q2 2022 Jul 29, 2022	BUY	$4.77 - $6.67 $293,750 - $410,758	61,583 New	61,583 $392,000
Q1 2022 Apr 29, 2022	SELL	$3.34 - $5.56 $369,116 - $614,457	-110,514 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$4.81 - $11.92 $42,972 - $106,493	8,934 Added 8.8%	110,514 $553,000
Q3 2021 Nov 01, 2021	BUY	$11.34 - $21.37 $994,926 - $1.87 Million	87,736 Added 633.75%	101,580 $1.22 Million
Q2 2021 Aug 12, 2021	SELL	$19.4 - $28.71 $46,986 - $69,535	-2,422 Reduced 14.89%	13,844 $293,000
Q1 2021 May 13, 2021	BUY	$25.12 - $36.89 $18,011 - $26,450	717 Added 4.61%	16,266 $456,000
Q4 2020 Feb 04, 2021	SELL	$24.2 - $35.76 $200,134 - $295,735	-8,270 Reduced 34.72%	15,549 $404,000
Q3 2020 Nov 09, 2020	BUY	$31.18 - $52.71 $573,867 - $970,127	18,405 Added 339.95%	23,819 $885,000
Q2 2020 Jul 20, 2020	SELL	$30.04 - $51.31 $668,029 - $1.14 Million	-22,238 Reduced 80.42%	5,414 $278,000
Q1 2020 Apr 30, 2020	BUY	$27.44 - $73.84 $194,522 - $523,451	7,089 Added 34.47%	27,652 $872,000
Q4 2019 Jan 28, 2020	BUY	$35.4 - $59.82 $727,930 - $1.23 Million	20,563 New	20,563 $1.23 Million
Q2 2019 Jul 29, 2019	SELL	$40.1 - $52.33 $595,084 - $776,577	-14,840 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$40.11 - $53.57 $418,547 - $559,002	10,435 Added 236.89%	14,840 $596,000
Q4 2018 Feb 01, 2019	BUY	$36.99 - $59.11 $162,940 - $260,379	4,405 New	4,405 $203,000
Q3 2018 Nov 06, 2018	SELL	$40.74 - $51.41 $1.11 Million - $1.4 Million	-27,319 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$36.2 - $76.4 $2.3 Million - $4.86 Million	-63,654 Reduced 69.97%	27,319 $1.07 Million
Q1 2018 May 03, 2018	BUY	$65.94 - $80.76 $5.8 Million - $7.1 Million	87,950 Added 2909.36%	90,973 $6.58 Million
Q4 2017 Jan 24, 2018	SELL	$43.47 - $67.43 $17,388 - $26,972	-400 Reduced 11.69%	3,023 $199,000
Q3 2017 Nov 07, 2017	BUY	$43.8 - $52.77 $149,927 - $180,631	3,423	3,423 $172,000

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Esperion Therapeutics, Inc. Transaction History